the beta-blocker heart attack trial ( bhat ) was a placebo-controlled , randomized , double-blind clinical trial of the long-term administration of propranolol hydrochloride to persons who had had at least one confirmed myocardial infarction .
C0282321
propranolol
C0027051
myocardial